AORT vs KIDS
AORT: Artivion is a leader in surgical solutions for aortic disease, combining proprietary stent grafts, mechanical heart valves, surgical sealants, and implantable tissue services. KIDS: OrthoPediatrics is a pediatric orthopedic device maker providing anatomically-tailored implants, instruments, and conservative treatment solutions designed specifically for children, with an expanding network of O&P clinics.
Side-by-side fundamentals
| Metric | AORT | KIDS | Edge |
|---|---|---|---|
| Price as of 2026-07-22 close | $25.14 | $19.26 | |
| Market cap as of 2026-07-23 | $1.2B | $495M | |
| P/E as of 2026-07-23 | 103.71 | n/a | |
| Net margin as of 2026-07-23 | +2.5% | -16.3% | AORT higher |
| Gross margin as of 2026-07-23 | +64.5% | +73.1% | KIDS higher |
| Operating margin as of 2026-07-23 | +6.0% | -15.0% | AORT higher |
| ROE as of 2026-07-23 | +2.7% | -11.4% | AORT higher |
| ROA as of 2026-07-23 | +1.4% | -7.9% | AORT higher |
| Debt / equity as of 2026-07-23 | 0.49 | 0.30 | KIDS lower |
| Revenue growth (YoY) as of 2026-07-23 | +17.6% | +14.5% | AORT higher |
| Revenue CAGR (3y) SEC XBRL | +12.0% | +24.6% | KIDS higher |
| Dividend streak (yrs) SEC XBRL | 0 | n/a | |
| Beta as of 2026-07-23 | 1.28 | 0.99 | |
| 1-year return as of 2026-07-22 close | -17.3% | -10.9% | KIDS higher |
Fundamentals: Finnhub, as of 2026-07-23. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-22.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.